208 related articles for article (PubMed ID: 27310569)
41. End-stage renal failure in adults with the tuberous sclerosis complex.
Clarke A; Hancock E; Kingswood C; Osborne JP
Nephrol Dial Transplant; 1999 Apr; 14(4):988-91. PubMed ID: 10328488
[TBL] [Abstract][Full Text] [Related]
42. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).
Pfeil AM; Imfeld P; Pettengell R; Jick SS; Szucs TD; Meier CR; Schwenkglenks M
Ann Hematol; 2015 Mar; 94(3):421-9. PubMed ID: 25219890
[TBL] [Abstract][Full Text] [Related]
43. Obesity and healthcare resource utilization: results from Clinical Practice Research Database (CPRD).
le Roux CW; Chubb B; Nørtoft E; Borglykke A
Obes Sci Pract; 2018 Oct; 4(5):409-416. PubMed ID: 30338111
[TBL] [Abstract][Full Text] [Related]
44. Kidney transplantation in patients with tuberous sclerosis complex.
Goedken AM; Ismail WW; Barrett LDG; Harshman LA
Pediatr Transplant; 2024 Jun; 28(4):e14765. PubMed ID: 38778713
[TBL] [Abstract][Full Text] [Related]
45. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
[TBL] [Abstract][Full Text] [Related]
46. Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex.
Vargiami E; Stabouli S; Sidira C; Kyriazi M; Anastasiou A; Notopoulos A; Zafeiriou D
Eur J Pediatr; 2022 Apr; 181(4):1465-1472. PubMed ID: 34988664
[TBL] [Abstract][Full Text] [Related]
47. An estimation of the incidence of tuberous sclerosis complex in a nationwide retrospective cohort study (1997-2010).
Hong CH; Tu HP; Lin JR; Lee CH
Br J Dermatol; 2016 Jun; 174(6):1282-9. PubMed ID: 26800857
[TBL] [Abstract][Full Text] [Related]
48. An Australian tuberous sclerosis cohort: are surveillance guidelines being met?
Chopra M; Lawson JA; Wilson M; Kennedy SE; Taylor P; Buckley MF; Wargon O; Parasivam G; Camphausen C; Yates D; Mowat D
J Paediatr Child Health; 2011 Oct; 47(10):711-6. PubMed ID: 21449900
[TBL] [Abstract][Full Text] [Related]
49. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
50. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
51. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review.
Hallett L; Foster T; Liu Z; Blieden M; Valentim J
Curr Med Res Opin; 2011 Aug; 27(8):1571-83. PubMed ID: 21692602
[TBL] [Abstract][Full Text] [Related]
52. Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies.
Saine ME; Carbonari DM; Newcomb CW; Gallagher AM; Blak BT; Roy JA; Wood J; Cardillo S; Hennessy S; Strom BL; Lo Re V
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1328-1335. PubMed ID: 31328342
[TBL] [Abstract][Full Text] [Related]
53. Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex.
Pfirmann P; Aupy J; Jambon E; Idier L; Prezelin-Reydit M; Fermis M; Devillard R; Grenier N; Combe C; Rigothier C
J Med Genet; 2021 Jan; 58(1):25-31. PubMed ID: 32409510
[TBL] [Abstract][Full Text] [Related]
54. [Clinical analyses of bilateral renal angiomyolipomas associated with tuberous sclerosis complex].
Huang Z; Li H; Ji Z; Xiao H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):935-7. PubMed ID: 24854916
[TBL] [Abstract][Full Text] [Related]
55. Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care.
Pounders AJ; Rushing GV; Mahida S; Nonyane BAS; Thomas EA; Tameez RS; Gipson TT
Ther Adv Rare Dis; 2022; 3():26330040221140125. PubMed ID: 37180419
[TBL] [Abstract][Full Text] [Related]
56. Tuberous sclerosis complex with end-stage renal failure.
Neumann HP; Brüggen V; Berger DP; Herbst E; Blum U; Morgenroth A; Schollmeyer P; Wetterauer U
Nephrol Dial Transplant; 1995; 10(3):349-53. PubMed ID: 7792029
[TBL] [Abstract][Full Text] [Related]
57. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
58. Renal lesion growth in children with tuberous sclerosis complex.
Ewalt DH; Sheffield E; Sparagana SP; Delgado MR; Roach ES
J Urol; 1998 Jul; 160(1):141-5. PubMed ID: 9628635
[TBL] [Abstract][Full Text] [Related]
59. Arachnoid cysts in tuberous sclerosis complex.
Boronat S; Caruso P; Auladell M; Van Eeghen A; Thiele EA
Brain Dev; 2014 Oct; 36(9):801-6. PubMed ID: 24325802
[TBL] [Abstract][Full Text] [Related]
60. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
